BioSig regains Nasdaq minimum bid price compliance effective Nov 13, 2024

Streamex Corp.

Nasdaq Staff notified BioSig on Nov 13, 2024 that it regained compliance with Listing Rule 5550(a)(2).
Compliance achieved after closing bid price remained at $1.00 or higher for 10 consecutive business days through Nov 12, 2024.
CEO Anthony Amato expressed gratitude for shareholder support and commitment to increasing value.
Prior bid price deficiency notice from Oct 24, 2024 is now closed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.